Grand Hôpital de Charleroi
Gilly, Belgium
14 recruiting
Showing 1–20 of 26 trials
Recruiting
Phase 3
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
Early Breast CancerPremenopausal Breast CancerHR+/HER2- Breast Cancer
UNICANCER3,380 enrolled105 locationsNCT07106632
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled270 locationsNCT06152575
Recruiting
Phase 3
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled285 locationsNCT07222800
Recruiting
Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-small Cell Lung CancerCarcinoma, Non-Small Cell LungCarcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer714 enrolled372 locationsNCT06758401
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled632 locationsNCT06935370
Recruiting
Phase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Boehringer Ingelheim6,000 enrolled652 locationsNCT06424288
Recruiting
Phase 2Phase 3
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Metastatic Pancreatic Ductal AdenocarcinomaCachexia
Pfizer982 enrolled214 locationsNCT06989437
Recruiting
Phase 3
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Multiple Myeloma
Pfizer1,116 enrolled127 locationsNCT05623020
Recruiting
Phase 3
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Endometrial CancerRecurrent or Progressive Endometrial Cancer
Genmab660 enrolled120 locationsNCT07166094
Recruiting
Not Applicable
R³ Rehab Pathway Versus Usual Care After Lumbar Radicular Surgery
Lumbar RadiculopathyRadicular Low Back Pain
Universitaire Ziekenhuizen KU Leuven480 enrolled16 locationsNCT07313566
Recruiting
AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.
Lymphoma, Non-HodgkinCare Coordination
Grand Hôpital de Charleroi210 enrolled1 locationNCT07546188
Recruiting
Phase 2
Study of Lacutamab in Peripheral T-cell Lymphoma
Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837
Recruiting
Not Applicable
Assessing the Japet.W+ Lumbar Traction Device in Rehabilitation for Patients With Non-specific Mechanical Low Back Pain
Low Back Pain, Mechanical
Grand Hôpital de Charleroi60 enrolled1 locationNCT06718348
Recruiting
Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation
Upper Limb Ischemia
Grand Hôpital de Charleroi100 enrolled2 locationsNCT06569771
Recruiting
Phase 4
Proactive TDM Versus Standard Use of Biologics in Psoriasis
Psoriasis Vulgaris
University Hospital, Ghent210 enrolled15 locationsNCT06398106
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Not Applicable
Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
Radiotherapy Side EffectGlioblastoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain347 enrolled23 locationsNCT06719440
Recruiting
Phase 3
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Metastatic HER2-positive Breast Cancer
Jazz Pharmaceuticals550 enrolled166 locationsNCT06435429
Recruiting
Not Applicable
A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
CNS Metastases
Jules Bordet Institute600 enrolled17 locationsNCT04109131
Recruiting
Phase 3
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Metastatic CancerAdvanced Cancer
Daiichi Sankyo50 enrolled28 locationsNCT06174987